Helen Webberley Live on FB

[rogdmum]

Watch here:

www.facebook.com/gendergp/videos/d41d8cd9/682774969109152/

Or a bit of a Twitter summary by Eva Poen here:
twitter.com/evapoen/status/1334472987806928903?s=21

Oh my. That is all I will say. Oh my.

Why are parents prepared to give their children experimental drug treatment, prescribed by a GP who is currently suspended & operating from outside the UK? I genuinely don’t understand it.

I hope that the uk regulated pharmacies enabling the Webberleys by providing this service on their behalf are paying attention.

Thats the Webberleys who have been accused of a lack of professional due dilligence.

What interesting timing to go on a sales pitch at a time when there is concern within some circles that drugs will be withdrawn from availability via the NHS and the courts will now have to get involved.

Shall we exploit the suicide trope a bit more?

www.legislation.gov.uk/uksi/2008/1277/regulation/3/made

Prohibition of unfair commercial practices

3.—(1) Unfair commercial practices are prohibited.
(2) Paragraphs (3) and (4) set out the circumstances when a commercial practice is unfair.

(3) A commercial practice is unfair if—
^(a)it contravenes the requirements of professional diligence; and
(b)it materially distorts or is likely to materially distort the economic behaviour of the average consumer with regard to the product.

(4) A commercial practice is unfair if—
(a)it is a misleading action under the provisions of regulation 5;
(b)it is a misleading omission under the provisions of regulation 6;
(c)it is aggressive under the provisions of regulation 7; or
(d)it is listed in Schedule 1.

www.legislation.gov.uk/uksi/2008/1277/regulation/5/made

Misleading actions

5.—(1) A commercial practice is a misleading action if it satisfies the conditions in either paragraph (2) or paragraph (3).

(2) A commercial practice satisfies the conditions of this paragraph—

(a)if it contains false information and is therefore untruthful in relation to any of the matters in paragraph (4) or if it or its overall presentation in any way deceives or is likely to deceive the average consumer in relation to any of the matters in that paragraph, even if the information is factually correct; and

(b)it causes or is likely to cause the average consumer to take a transactional decision he would not have taken otherwise.

(3) A commercial practice satisfies the conditions of this paragraph if—

(a)it concerns any marketing of a product (including comparative advertising) which creates confusion with any products, trade marks, trade names or other distinguishing marks of a competitor; or

(b)it concerns any failure by a trader to comply with a commitment contained in a code of conduct which the trader has undertaken to comply with, if—

(i)the trader indicates in a commercial practice that he is bound by that code of conduct, and
(ii)the commitment is firm and capable of being verified and is not aspirational,

and it causes or is likely to cause the average consumer to take a transactional decision he would not have taken otherwise, taking account of its factual context and of all its features and circumstances.

(4) The matters referred to in paragraph (2)(a) are—

(a)the existence or nature of the product;

(b)the main characteristics of the product (as defined in paragraph 5);

(c)the extent of the trader’s commitments;

(d)the motives for the commercial practice;

(e)the nature of the sales process;

(f)any statement or symbol relating to direct or indirect sponsorship or approval of the trader or the product;

(g)the price or the manner in which the price is calculated;

(h)the existence of a specific price advantage;

(i)the need for a service, part, replacement or repair;

(j)the nature, attributes and rights of the trader (as defined in paragraph 6);

(k)the consumer’s rights or the risks he may face.

(5) In paragraph (4)(b), the “main characteristics of the product” include—

(a)availability of the product;
(b)benefits of the product;
(c)risks of the product;
(d)execution of the product;
(e)composition of the product;
(f)accessories of the product;
(g)after-sale customer assistance concerning the product;
(h)the handling of complaints about the product;
(i)the method and date of manufacture of the product;
(j)the method and date of provision of the product;
(k)delivery of the product;
(l)fitness for purpose of the product;
(m)usage of the product;
(n)quantity of the product;
(o)specification of the product;
(p)geographical or commercial origin of the product;
(q)results to be expected from use of the product; and
(r)results and material features of tests or checks carried out on the product.

(6) In paragraph (4)(j), the “nature, attributes and rights” as far as concern the trader include the trader’s—

(a)identity;
(b)assets;
(c)qualifications;
(d)status;
(e)approval;
(f)affiliations or connections;
(g)ownership of industrial, commercial or intellectual property rights; and
(h)awards and distinctions.

(7) In paragraph (4)(k) “consumer’s rights” include rights the consumer may have under Part 5A of the Sale of Goods Act 1979(1) or Part 1B of the Supply of Goods and Services Act 1982(2).

www.legislation.gov.uk/uksi/2008/1277/regulation/6/made

Misleading omissions

6.—(1) A commercial practice is a misleading omission if, in its factual context, taking account of the matters in paragraph (2)—

(a)the commercial practice omits material information,

(b)the commercial practice hides material information,

(c)the commercial practice provides material information in a manner which is unclear, unintelligible, ambiguous or untimely, or

(d)the commercial practice fails to identify its commercial intent, unless this is already apparent from the context,

and as a result it causes or is likely to cause the average consumer to take a transactional decision he would not have taken otherwise.

(2) The matters referred to in paragraph (1) are—

(a)all the features and circumstances of the commercial practice;

(b)the limitations of the medium used to communicate the commercial practice (including limitations of space or time); and

(c)where the medium used to communicate the commercial practice imposes limitations of space or time, any measures taken by the trader to make the information available to consumers by other means.

(3) In paragraph (1) “material information” means—

(a)the information which the average consumer needs, according to the context, to take an informed transactional decision; and

(b)any information requirement which applies in relation to a commercial communication as a result of a Community obligation.

(4) Where a commercial practice is an invitation to purchase, the following information will be material if not already apparent from the context in addition to any other information which is material information under paragraph (3)—

(a)the main characteristics of the product, to the extent appropriate to the medium by which the invitation to purchase is communicated and the product;

(b)the identity of the trader, such as his trading name, and the identity of any other trader on whose behalf the trader is acting;

(c)the geographical address of the trader and the geographical address of any other trader on whose behalf the trader is acting;

(d)either—

(i)the price, including any taxes; or

(ii)where the nature of the product is such that the price cannot reasonably be calculated in advance, the manner in which the price is calculated;

(e)where appropriate, either—

(i)all additional freight, delivery or postal charges; or

(ii)where such charges cannot reasonably be calculated in advance, the fact that such charges may be payable;

(f)the following matters where they depart from the requirements of professional diligence—

(i)arrangements for payment,

(ii)arrangements for delivery,

(iii)arrangements for performance,

(iv)complaint handling policy;

(g)for products and transactions involving a right of withdrawal or cancellation, the existence of such a right.

www.legislation.gov.uk/uksi/2008/1277/regulation/7/made

Aggressive commercial practices
7.—(1) A commercial practice is aggressive if, in its factual context, taking account of all of its features and circumstances—

(a)it significantly impairs or is likely significantly to impair the average consumer’s freedom of choice or conduct in relation to the product concerned through the use of harassment, coercion or undue influence; and

(b)it thereby causes or is likely to cause him to take a transactional decision he would not have taken otherwise.

(2) In determining whether a commercial practice uses harassment, coercion or undue influence account shall be taken of—

(a)its timing, location, nature or persistence;

(b)the use of threatening or abusive language or behaviour;

(c)the exploitation by the trader of any specific misfortune or circumstance of such gravity as to impair the consumer’s judgment, of which the trader is aware, to influence the consumer’s decision with regard to the product;

(d)any onerous or disproportionate non-contractual barrier imposed by the trader where a consumer wishes to exercise rights under the contract, including rights to terminate a contract or to switch to another product or another trader; and

(e)any threat to take any action which cannot legally be taken.

(3) In this regulation—

(a)“coercion” includes the use of physical force; and

(b)“undue influence” means exploiting a position of power in relation to the consumer so as to apply pressure, even without using or threatening to use physical force, in a way which significantly limits the consumer’s ability to make an informed decision.

The whole of the The Consumer Protection from Unfair Trading Regulations 2008 makes for interesting reading:

www.legislation.gov.uk/uksi/2008/1277/contents/made

This is the legislation that protect adults and children, who 'by virtue of their circumstances' are classified as 'vulnerable' eg anyone who was suffering mental distress, impairment or are simply under the age at which they can reasonably consent...

There is a thread on Twitter with more detailed information on the question of 'Who owns GenderGP'

twitter.com/DanialWebb/status/1334617840431886336

The thread unrolled: threadreaderapp.com/thread/1334617840431886336.html

Who owns GenderGP, the online transgender affirmative care provider and prescriber of pubery blockers and cross-sex hormones to children and young people in the United Kingdom. This has become a highly pertinent question as doubtless many parents will be seeking their services. 1
GenderGP was founded by Dr Helen Webberley, a GP who was suspended by the GMC in 2018 for running an unlicensed clinic that gave hormones to children as young as 12. Helen moved her clinic to Malaga with her husband Dr Mike Webberley, who was also suspended by the GMC. 2
After this, things get murky. GenderGP claim that their business was acquired by Harland International, which claims to be "a global organisation providing advocacy services for LGBTQI people globally" and is incorporated in Hong Kong. 3
Harland International's registered office is in Kiu Yin Commercial Building, and shares an office with Jinetic Consultants Ltd, a company specialising in off-the-shelf companies and corporate address facilities. It has a single director, a Miss Genevieve Yolanda Pennill. 4
Miss Pennill appears to live either Belize or York and is clearly someone who makes their living being a front director. You can find her in the infamous trove of Panama Papers as director of Milan Commodities Limited. 5
Miss Pennill was also registered as a director in the UK, a s director of a company called Bridgwater Tankwash Limited. She was appointed 5 Nov 2010 and resigned 3 Aug 2011. Its company secretary is a company called Turner Little Company Secretaries Limited. 6
Turner Little are another company formation company, also based in York. Among their hundreds of clients are... Gender GP limited, who use Turner Little as a correspondence address. 7
Helen Webberley resigned from Gender GP limited on 5 April 2019, on the same day that a new director, Lidia Feria Palmero, was appointed. Lida and Helen Webberley have been on the boards of three companies together, GenderGP Ltd, Online GP Services Ltd and My Web Doctor Ltd 8
Lidia is also director of Simply Underfloor Heating Ltd, based in, by remarkable coincidence, Kiu Yin Commercial Building, in the same office as Harland International. 9
These days Helen is limited to a single company directorship, Spectrum Support Services, based in Malaga. Hong Kong law makes it impossible to find out the true beneficiaries of Harland International. You can decide for yourself what to believe. 10

These days Helen is limited to a single company directorship, Spectrum Support Services, based in Malaga.

That's no longer true. Helen Webberley was reinstated as director of My Web Doctor on 9th October, when Lidia Feria Palmero resigned as director.

find-and-update.company-information.service.gov.uk/company/09306407/officers

Thanks, OldCrone.

[quote OldCrone]These days Helen is limited to a single company directorship, Spectrum Support Services, based in Malaga.

That's no longer true. Helen Webberley was reinstated as director of My Web Doctor on 9th October, when Lidia Feria Palmero resigned as director.

find-and-update.company-information.service.gov.uk/company/09306407/officers[/quote]
Just adding to my earlier post.

According to Companies House, Spectrum Support Services Ltd is based in Belize, and is listed as a director of another company, Asaar Technology Ltd, along with Mike Webberley. The 'Nature of Business' for Asaar is described as 'Activities of other holding companies not elsewhere classified'

find-and-update.company-information.service.gov.uk/company/11716120/officers

Spectrum Support Services and Mike Webberley became directors of Asaar Tech in April 2019. Previously the only director was Konstantin Nemchukov from December 2018 when the company was set up. Nemchukov, who is Russian, is currently director of 30 UK companies and has been associated with a total of 337.

find-and-update.company-information.service.gov.uk/officers/ut7zZr1fmyjheWzrkd6newPJLRo/appointments

I have no idea what's going on here.

Marianne appears to be saying that anyone attending a GP wanting treatment should be given treatment because they wouldn't have asked for it if they weren't trangender.

How would she explain the rising number of detransitioners then? I’ve heard genderists claim that anyone detrans was never truly trans anyway, but if they asked for treatment they must be?

It all falls apart with just the teensiest application of logic doesn’t it

@Lordamighty

Why are parents prepared to give their children experimental drug treatment, prescribed by a GP who is currently suspended & operating from outside the UK? I genuinely don’t understand it.

Because they've been manipulated to believe that their children will commit suicide if they don't get the treatment.

Also, some socially conservative/religious parents with poor scientific knowledge find it easier and more palatable to believe that their child was born in the wrong body - i.e. has a pink brain in a blue body, or vice versa - than to accept that their child is an effeminate boy or an unacceptably masculine boy and/or same-sex attracted.

... because then it can be treated like a medical problem - on the lines of 'My child has Type 1 diabetes because her body doesn't make insulin, so she will take insulin for the rest of her life to make up for this' - so 'My child was born with the wrong body for her brain so doctors are going to stop her body going through male puberty and then they'll give her more drugs to stop her producing testosterone and put in the oestrogen and progesterone she should have had all along and in due course they will perform the surgery to make her look like she should have done in the first place'.

I have no idea what's going on here.

A shell game?

Here's a hit for Konstantin Nemchukov:

www.scamwarners.com/forum/viewtopic.php?p=355963

The fruit garden of the Southern lands posits that a bespectacled dr has been sanctioned in UK, and is joining fellow medicos in Spain. No idea if these allegations are based in any realm of current reality, but it is 2020.

Oh dear tannins. Would not surprise anyone. And we already know that person cannot think beyond the superficial, so sadly will not give these diagnosis the attention they need.

It sounds like they bought a shelf company. This is fairly common practice, especially when someone wants a company in a hurry. They can be used nefariously, but buying one is also standard practice. The company is already set up (presumably by Konstantin's firm) and registered, the buyer then just has to change the directors and shareholders.

The offshore companies will be about privacy and/or tax, though of course can also be used to cover up fraud and tax evasion.

Worrying lack of understanding of consent for a medical professional.

Gawd if that’s true tannin it makes even more of a laughing stock of GenderGP if that’s possible - does that chap have any specialist training in psychiatry or endocrinology? Background is general practice and emergency medicine I believe and mostly as a locum (nothing specifically against locums, I did a lot of locum work myself when I was younger, you get a nice breadth of experience, but depth is restricted, you don’t get long term follow up of your cases, which is a bit of a handicap). Not the experienced specialist you’d want managing your distressed child’s care.

Surely trans people and anyone suffering gender dysphoria deserve professionals who are trained, experienced and qualified in the relevant areas of medicine managing their care, not just any idealogue with a medical degree running from professional sanctions happy to prescribe at will. Why is the TRA lobby not demanding higher standards of healthcare, evidence based with safeguarding and professionalism at the forefront?

Although there was that “trans health” manifesto demanding all hormonal medication free on demand and that trans people be allowed to perform surgery on each other, so I guess it’s not that surprising. Gatekeeping having been made a dirty word now and all.

I half wish that Stonewall, Mermaids, Gender GP etc had been allowed to give evidence in this case because the outcome would have been exactly the same.